Kerri Rawson visited the family of Rex Heuermann at their Long Island home, saying in a new documentary, "I know what it's ...

With a distribution agreement in place and an option to acquire Contego Medical, Medtronic’s peripheral vascular division ki ...

During a live event, Danielle M. Brander, MD, discussed use of zanubrutinib in high-risk chronic lymphocytic leukemia.

An oral tablet formulation of zanubrutinib was approved for use in patients with certain lymphomas or leukemia and ...

Panelists discuss how lower out-of-pocket costs resulting from ibrutinib’s inclusion in the Inflation Reduction Act (IRA) might improve the affordability and utilization of BTK inhibitor treatments in ...

Panelists discuss how the Inflation Reduction Act (IRA) might influence health care systems’ selection and utilization of Bruton tyrosine kinase (BTK) inhibitors, particularly through changes in ...

EVER001 is a covalent reversible BTK inhibitor with potentially best-in-class characteristics for the treatment of primary membranous nephropathy (pMN) and other autoimmune renal diseases ...

Sino-American oncology company BeOne Medicines (Nasdaq: ONC) is presenting new clinical data from cornerstone hematology assets at the European Hematology Association (EHA) Congress.

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will present new clinical data from three cornerstone hematology assets at the European Hematology Association ...